Previous 10 | Next 10 |
2023-08-01 10:04:48 ET Gainers: Adamis Pharmaceuticals ( ADMP ) +71% . ABVC BioPharma ( ABVC ) +49% . EQRx ( EQRX ) +18% . Rhythm Pharmaceuticals ( RYTM ) +17% . Esperion Therapeutics ( ESPR ) +6% . Losers: TG Therapeu...
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation ( NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the Company has committed to fund an unrestricted research grant to the Leiden University Medical Center (LUMC) Anesthesia and Pai...
2023-07-28 08:23:12 ET Reata Pharmaceuticals ( RETA ) +51% agrees to buy Reata Pharmaceuticals in deal valued at $7.3B . SIGA Technologies ( SIGA ) +32% jumps 27% on U.S. government orders worth $138M. Coursera ( COUR ) +17% Q2 earnings call release INV...
2023-06-26 09:28:00 ET U.S. stock index futures on Monday pointed to a lower open. Wall Street's benchmark S&P 500 ( SP500 ) index on Friday posted its worst week since early March, with sentiment weighed down by concerns over the future of the Federal Reserve's monetary policy....
SAN DIEGO, June 26, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced that its wholly owned subsidiary DMK Pharmaceuticals Corporation was the recipient of a grant from the National Institute on Alcohol Ab...
SAN DIEGO, June 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced that Eboo Versi, MD, PhD, CEO of Adamis Pharmaceuticals is proud and excited to have participated in the White House Roundtable with Op...
2023-05-26 13:21:20 ET Gainers: Elevation Oncology ( ELEV ) +70% . Alarum Technologies ( ALAR ) +61% . Bright Health Group ( BHG ) +56% . Onfolio Holdings ( ONFO ) +35% . D-Wave Quantum ( QBTS ) +31% . Marvell Technology ( ...
DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined company Combined company will have commercial products and a library of development candidates, including two clinical stage programs DPI-125, the lead development program, is a clinical stage therapeutic under...
2023-05-22 08:53:42 ET Rain Oncology ( RAIN ) +-82% Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcoma. Volcon ( VLCN ) +-30% slides after announcing new equity offering. Mallinckrodt ( MNK...
2023-05-19 12:34:48 ET Adamis Pharmaceuticals ( NASDAQ: ADMP ) fell ~19% on Friday after announcing plans to effect a 1-for-70 reverse stock split of its common stock from next week. Accordingly, the reverse stock split will take effect on May 22, 2023, at 12:01 a.m., and ...
News, Short Squeeze, Breakout and More Instantly...
Adamis Pharmaceuticals Corporation Company Name:
ADMP Stock Symbol:
NASDAQ Market:
Adamis Pharmaceuticals Corporation Website:
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK Pharmaceuticals Corporation in order to better reflect its new strategic focus on advancing sm...
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2023, and provided an update on recent corporate developments. Q2 2023 ...
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock (or pre-funded warrant in...